03.10.14
United Orthopedic Corporation (UOC) – an international designer, manufacturer, and distributor of orthopedic implants and instruments – is entering the American market, offering hip and knee devices through its U.S. subsidiary, UOC USA.
“United Orthopedic Corporation is the first Asian orthopedic company to receive FDA [U.S. Food and Drug Administration] approval for joint reconstruction,” said Calvin Lin, president of UOC USA. “For the past 20 years, we’ve been recognized for our products and we are excited to bring our line of hip and knee replacement systems to American orthopedic surgeons.”
Established in 1993 and headquartered in Taiwan, UOC has been supplying and supporting orthopedic practitioners and institutions around the world with arthroplasty implant and instrument designs created by its vertically integrated, in-house manufacturing team. Its designs are based on firsthand practitioner input, as well as rigorous clinical research, and are known for meeting world quality assurance standards.
“I’ve used the U2 Knee System from UOC and believe the design and quality of UOC’s products can help to improve the lives of arthroplasty patients all around the world,” said Thomas Ferro, M.D., an orthopedic surgeon and medical director at the Bone and Joint Center in Arroyo Grande, Calif. “In addition to quality joint replacement systems with great range of motion, UOC also offers surgeon-friendly instrument design which saves time on the operating table.”
“Because our manufacturing process is vertically integrated,” continued Lin, “we are able to oversee every aspect of our products’ manufacturing – from the initial design to packaging the finished product.”
According to the Centers for Disease Control and Prevention, 332,000 hip and 719,000 knee replacements are performed in the United States each year to increase mobility, improve joint function and relieve pain.
The company will be on hand (in booth 6149) during this week's annual meeting of the American Academy of Orthopaedic Surgeons in New Orleans, La. (March 11-15).
“United Orthopedic Corporation is the first Asian orthopedic company to receive FDA [U.S. Food and Drug Administration] approval for joint reconstruction,” said Calvin Lin, president of UOC USA. “For the past 20 years, we’ve been recognized for our products and we are excited to bring our line of hip and knee replacement systems to American orthopedic surgeons.”
Established in 1993 and headquartered in Taiwan, UOC has been supplying and supporting orthopedic practitioners and institutions around the world with arthroplasty implant and instrument designs created by its vertically integrated, in-house manufacturing team. Its designs are based on firsthand practitioner input, as well as rigorous clinical research, and are known for meeting world quality assurance standards.
“I’ve used the U2 Knee System from UOC and believe the design and quality of UOC’s products can help to improve the lives of arthroplasty patients all around the world,” said Thomas Ferro, M.D., an orthopedic surgeon and medical director at the Bone and Joint Center in Arroyo Grande, Calif. “In addition to quality joint replacement systems with great range of motion, UOC also offers surgeon-friendly instrument design which saves time on the operating table.”
“Because our manufacturing process is vertically integrated,” continued Lin, “we are able to oversee every aspect of our products’ manufacturing – from the initial design to packaging the finished product.”
According to the Centers for Disease Control and Prevention, 332,000 hip and 719,000 knee replacements are performed in the United States each year to increase mobility, improve joint function and relieve pain.
The company will be on hand (in booth 6149) during this week's annual meeting of the American Academy of Orthopaedic Surgeons in New Orleans, La. (March 11-15).